Novo Nordisk diabetes drug appears effective for weight loss: study
(Reuters) - Novo Nordisk's big-selling diabetes drug Victoza appears to be an effective weight loss therapy, data from a late-stage clinical trial presented on Saturday demonstrated. (Source: Reuters: Health)
Source: Reuters: Health - June 14, 2014 Category: Consumer Health News Tags: healthNews Source Type: news
Victoza Accused of Causing Pancreatitis
(MedPage Today) -- The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide (Victoza) likely causes pancreatitis, the group said. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 6, 2014 Category: Cardiology Source Type: news
Hope on Horizon for Newer Obesity Drugs in Europe?Hope on Horizon for Newer Obesity Drugs in Europe?
The lack of obesity drugs in Europe was the focus of much discussion at the European Conference on Obesity last week. Hopes are high that bupropion/naltrexone and liraglutide will soon be approved there. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 4, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Diabetes Drug May Spur Weight Loss in Obese Nondiabetics
One-third who took Victoza lost 10 percent of body weight, researchers say (Source: WebMD Health)
Source: WebMD Health - May 30, 2014 Category: Consumer Health News Source Type: news
Diabetes Drug May Spur Weight Loss in Obese Nondiabetics
One-third who took Victoza lost 10 percent of body weight, researchers say
Source: HealthDay
Related MedlinePlus Pages: Diabetes Medicines, Weight Control (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 29, 2014 Category: Consumer Health News Source Type: news
